Overview Dosage Guide Side Effects Protocol Results Weight Loss Clinical Trials Injection Guide GLP-3 How to Get CostFDA ApprovalAvailability Telehealth Liver Fat Muscle Loss Where to Buy

Is Tirzepatide FDA Approved? Status & Timeline

Yes — Tirzepatide is FDA approved. Here's what that means for access, prescribing, and insurance coverage.

FDA APPROVED

FDA approved for T2D (Mounjaro, 2022) and obesity (Zepbound, 2023)

Current Legal Status

FDA approved. Requires prescription. Available via physician or telehealth provider.

Clinical Trial Results

Tirzepatide has been studied in multiple clinical trials. Here's a summary of the key findings:

Phase 3 (SURMOUNT-1)

Weight reduction in adults with obesity

Participants on 15mg tirzepatide lost an average of 22.5% of body weight over 72 weeks, compared to 2.4% for placebo.

Source: NEJM 2022; SURMOUNT-1

Phase 3 (SURPASS-2)

HbA1c reduction vs semaglutide in T2D

Tirzepatide 15mg reduced HbA1c by 2.46% vs 2.33% for semaglutide 1mg, and produced greater weight loss (12.4kg vs 6.2kg).

Source: NEJM 2021; SURPASS-2

What Approval Means for You

💊

Prescription access

FDA approval allows licensed physicians to prescribe it. Telehealth platforms offer it within months.

🏥

Insurance coverage path

Coverage is expanding. Coverage won't be automatic — you'll need to meet criteria.

🧪

Compounding availability

Compounding pharmacies can produce it — especially if drug shortages emerge.

✅

Quality assurance

FDA oversight means standardized manufacturing, labeling, and purity requirements that research chemicals lack.

Frequently Asked Questions

Is Tirzepatide FDA approved?

Yes. Tirzepatide has received FDA approval. FDA approved for T2D (Mounjaro, 2022) and obesity (Zepbound, 2023)

What phase are Tirzepatide clinical trials in?

Phase 3 (SURMOUNT-1): Participants on 15mg tirzepatide lost an average of 22.5% of body weight over 72 weeks, compared to 2.4% for placebo. Phase 3 (SURPASS-2): Tirzepatide 15mg reduced HbA1c by 2.46% vs 2.33% for semaglutide 1mg, and produced greater weight loss (12.4kg vs 6.2kg).

When will Tirzepatide be FDA approved?

Tirzepatide is already FDA approved.

What happens to Tirzepatide access after FDA approval?

FDA approval means Tirzepatide can be legally prescribed by physicians, dispensed by licensed pharmacies, and eventually covered by insurance. It also unlocks the possibility of compounding pharmacy versions if supply shortages occur.

Can I use Tirzepatide before it's for non-approved indications?

Yes — with a valid prescription from a licensed healthcare provider. Off-label use (for conditions not in the approved label) is legal under physician judgment.

References & Sources

Exploring Retatrutide Access?

See how patients are accessing retatrutide through physician-supervised telehealth and compounding pharmacies.

Not FDA approved. Access requires physician oversight.

Affiliate links — we may earn a commission at no cost to you.

Compare Providers →

Disclaimer: Regulatory timelines are estimates based on publicly available information. FDA decisions are subject to change. This page is updated periodically but should not be used as the sole source for regulatory decisions.